Royal Bank of Canada’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9M | Buy |
|
|||||
|
2025
Q1 | $9.96M | Buy |
|
|||||
|
2024
Q4 | $8.92M | Buy |
|
|||||
|
2024
Q3 | $4.59M | Sell |
|
|||||
|
2024
Q2 | $11.3M | Sell |
|
|||||
|
2024
Q1 | $12.5M | Sell |
|
|||||
|
2023
Q4 | $15.6M | Buy |
|
|||||
|
2023
Q3 | $14.1M | Sell |
|
|||||
|
2023
Q2 | $16.5M | Sell |
|
|||||
|
2023
Q1 | $20.9M | Buy |
|
|||||
|
2022
Q4 | $18.5M | Buy |
|
|||||
|
2022
Q3 | $14.1M | Buy |
|
|||||
|
2022
Q2 | $12.9M | Buy |
|
|||||
|
2022
Q1 | $11.8M | Buy |
|
|||||
|
2021
Q4 | $10.4M | Buy |
|
|||||
|
2021
Q3 | $8.94M | Sell |
|
|||||
|
2021
Q2 | $12.2M | Buy |
|
|||||
|
2021
Q1 | $7.64M | Buy |
|
|||||
|
2020
Q4 | $7.64M | Sell |
|
|||||
|
2020
Q3 | $7.86M | Sell |
|
|||||
|
2020
Q2 | $14.9M | Buy |
|
|||||
|
2020
Q1 | $4.93M | Buy |
|
|||||
|
2019
Q4 | $4.58M | Buy |
|
|||||
|
2019
Q3 | $3.05M | Buy |
|
|||||
|
2019
Q2 | $3.33M | Buy |
|
|||||
|
2019
Q1 | $2.91M | Sell |
|
|||||
|
2018
Q4 | $3.35M | Buy |
|
|||||
|
2018
Q3 | $3.57M | Sell |
|
|||||
|
2018
Q2 | $3.6M | Sell |
|
|||||
|
2018
Q1 | $4.06M | Buy |
|
|||||
|
2017
Q4 | $3.37M | Buy |
|
|||||
|
2017
Q3 | $3.19M | Sell |
|
|||||
|
2017
Q2 | $3.83M | Buy |
|
|||||
|
2017
Q1 | $3.52M | Buy |
|
|||||
|
2016
Q4 | $2.75M | Sell |
|
|||||
|
2016
Q3 | $3.51M | Buy |
|
|||||
|
2016
Q2 | $2.04M | Buy |
|
|||||
|
2016
Q1 | $1.98M | Sell |
|
|||||
|
2015
Q4 | $5.21M | Buy |
|
|||||
|
2015
Q3 | $4.84M | Buy |
|
|||||
|
2015
Q2 | $5.91M | Sell |
|
|||||
|
2015
Q1 | $6.49M | Sell |
|
|||||
|
2014
Q4 | $9.73M | Buy |
|
|||||
|
2014
Q3 | $7.4M | Sell |
|
|||||
|
2014
Q2 | $6.98M | Buy |
|
|||||
|
2014
Q1 | $3.44M | Buy |
|
|||||
|
2013
Q4 | $3.09M | Sell |
|
|||||
|
2013
Q3 | $3.19M | Buy |
|
|||||
|
2013
Q2 | $1.01M | Buy |
|